Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Seagen Inc. - Common Stock (NQ:SGEN)

N/A UNCHANGED
Last Price Updated: 4:00 PM EST, Dec 13, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Seagen Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
17 18 Next >
SGEN Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Seagen Inc. Is Fair to Shareholders
From Halper Sadeh LLC
Via Business Wire
Pfizer Officially Nabs Seagen For $43 Billion; Provention Soars On Sanofi Deal
Pfizer expects Seagen to add at least $10 billion to its topline in 2030. 
Via Investor's Business Daily
Seagen's $43B Deal To Double Pfizer's Early-Stage Oncology Pipeline, Seagen Says Is Right Step
 
Via Benzinga
Pfizer Is Sending Seagen Stock Soaring Monday: What's Going On?
Seagen Inc (NASDAQ: SGEN) shares are trading higher Monday after Pfizer Inc (NYSE: PFE) announced plans to acquire the global biotech company. 
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
We're starting off the week with a breakdown of the biggest pre-market stock movers traders need to know about for Monday! 
Via InvestorPlace
(SGEN) - Analyzing Seagen's Short Interest
 
Via Benzinga
Analyst Expectations for Seagen's Future
 
Via Benzinga
Here's How Much You Would Have Made Owning Seagen Stock In The Last 5 Years
 
Via Benzinga
Pfizer Invests $43 Billion to Battle Cancer
From Seagen Inc.
Via Business Wire
Astellas and Seagen Announce China’s National Medical Products Administration Accepts Biologics License Application for Enfortumab Vedotin in Certain Patients with Locally Advanced or Metastatic Urothelial Cancer
From Seagen Inc.
Via Business Wire
Pfizer Is Targeting an Acquisition That Could Be a Game Changer for Its Business
The company is rumored to be interested in buying Seagen. 
Via The Motley Fool
Seagen, Delta Air Lines And 2 Other Stocks Insiders Are Selling
The Nasdaq 100 closed slightly lower on Tuesday. Investors, meanwhile, focused on some notable insider trades. 
Via Benzinga
Why Seagen Stock Perked Up Today
Rumors of another buyout are pushing the drugmaker's shares higher today. 
Via The Motley Fool
Top 5 Health Care Stocks That You May Want To Dump In Q1 2023
The most overbought stocks in the health care sector presents an opportunity to go short on these overvalued companies. 
Via Benzinga
US Stocks Recover After Recording Worst Week Of 2023, Market Volatility Declines
US stocks settled slightly higher on Monday, after Wall Street's major benchmarks recorded the biggest percentage declines of the year during the last week. On the economic data front, durable goods... 
Via Benzinga
U.S. Stock Market Today: Today's Biggest Market Movers
The stock market is digesting recent inflation data and earnings reports. Where is the stock market headed next? 
Via The Motley Fool
Analyst Cautions Investors On Overreacting To 'Early-Stage' Pfizer/Seagen Discussions
 
Via Benzinga
UNP Stock Alert: What to Know as Union Pacific’s CEO Steps Down
Union Pacific (UNP) stock is a hot topic among traders on Monday as its CEO prepares to step down this year to make room for a replacement. 
Via InvestorPlace
Why Smith Micro Software Shares Are Trading Lower By Over 46%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Gainers Lucira Health, Inc. (NASDAQ: LHDX) jumped 354% to $0.6369 after the company announced FDA authorization for its at-home combination COVID-19 & flu test. 
Via Benzinga
The $30 Billion Reason Seagen (SGEN) Stock Is Up 11% Today
SGEN stock is climbing about 11% in early trading. Pfizer is reportedly interested in buying the biotech for its line of cancer treatments. 
Via InvestorPlace
Union Pacific, Kosmos Energy, Fisker And Other Big Stocks Moving Higher On Monday
U.S. stocks traded higher, with the Dow Jones gaining more than 300 points on Monday. Here are some big stocks recording gains in today’s session. 
Via Benzinga
'Here We Go Again': Seagen Soars As Pfizer Reportedly Mulls A Takeover
The potential deal follows rumors last year that Merck could buy Seagen. 
Via Investor's Business Daily
Seagen Stock Soars On Pfizer Takeover Talks: What's Going On?
Seagen Inc (NASDAQ: SGEN) shares are trading higher Monday following reports indicating pharmaceutical giant Pfizer Inc (NYSE: 
Via Benzinga
Li Auto Powers Up, but Another Stock Is Really Stepping on the Gas
The stock market looked poised to climb on Monday morning. 
Via The Motley Fool
Seagen to Present at the Cowen 43rd Annual Health Care Conference
From Seagen Inc.
Via Business Wire
Why Lucira Health Shares Are Trading Higher By Over 228%; Here Are 20 Stocks Moving Premarket
Gainers Lucira Health, Inc. (NASDAQ: LHDX) rose 228.5% to $0.46 in pre-market trading after the FDA authorized Lucira's over-the-counter at-home test to detect both influenza and COVID-19 viruses. 
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
We're starting off Monday with a breakdown of the biggest pre-market stock movers investors will want to keep an eye on! 
Via InvestorPlace
Nasdaq, S&P 500 Futures Rebound In New Trading Week But Rising Bond Yields Remain A Risk
US stocks are coming off a lackluster week and early indications suggest a reversal in sentiment in the new trading week. While rising bond yields could be a cause of concern, the recent weakness could... 
Via Benzinga
Seagen, Occidental Petroleum And 3 Stocks To Watch Heading Into Monday
With US futures trading higher this morning on Monday, some of the stocks that may grab investor focus today are as follows: 
Via Benzinga
Pfizer In Early Talks To Buy Cancer-Focused Seagen: WSJ
 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9
...
17 18 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.